Contact
searchSearch
HMP Global
Conference Coverage

Gil Melmed, MD, on COVID-19 Vaccination Responses and Safety in Patients with IBD

12/21/2022

Dr Melmed reviews the results of studies regarding the response to and safety of COVID-19 vaccination among patients with IBD.

Gil Melmed, MD, is director of Inflammatory Bowel Disease Clinical Research, and codirector of Clinical Inflammatory Bowel Disease at Cedars Sinai Medical Center in Los Angeles, California.

Popular Articles

News
In Behçet Disease, Sleep Plays Crucial Role in Patient-Reported Outcomes
02/05/2021
Lifestyle factors may influence the onset, disease course, and the severity of inflammation among patients with chronic and inflammatory disorders. What is the association of various lifestyle factors with self-rated wellness and health...
Lifestyle factors may influence the onset, disease course, and the severity of inflammation among patients with chronic and inflammatory disorders. What is the association of various lifestyle factors with self-rated wellness and health...
Lifestyle factors may influence...
02/05/2021
Autoimmune
Pop Quiz: Mesalamine Recommendations
Quiz
Pop Quiz: Mesalamine Recommendations
12/04/2020
Are you familiar with the American Gastroenterological Association’s recommendation on treatments for left-sided mild to moderate ulcerative proctosigmoiditis or proctitis? Take our pop quiz to find out.
Are you familiar with the American Gastroenterological Association’s recommendation on treatments for left-sided mild to moderate ulcerative proctosigmoiditis or proctitis? Take our pop quiz to find out.
Are you familiar with the...
12/04/2020
Autoimmune
News
Predictors of Cardiovascular Events in PsA Are Identified
10/14/2020
Could the Disease Activity in Psoriatic Arthritis index predict cardiovascular events among patients with psoriatic arthritis? Here is what new research has revealed.
Could the Disease Activity in Psoriatic Arthritis index predict cardiovascular events among patients with psoriatic arthritis? Here is what new research has revealed.
Could the Disease Activity in...
10/14/2020
Autoimmune
News
IL-12/23, IL-23 Antagonists Increase Risk of Upper Respiratory Tract Infections
08/28/2020
Findings from a recent study showed an increased risk for upper respiratory tract infections among patients treated with IL-12/23 or IL-23 antagonists.
Findings from a recent study showed an increased risk for upper respiratory tract infections among patients treated with IL-12/23 or IL-23 antagonists.
Findings from a recent study...
08/28/2020
Autoimmune
Optimizing Treatment Regimens in Immune-Mediated Diseases
Conference Coverage
Optimizing Treatment Regimens in Immune-Mediated Diseases
07/12/2020
Research demonstrates that trough drug concentrations correlate to more positive outcomes in patients with immune-mediated diseases. At IAS 2020, David Hudesman, MD, and Adam Cheifetz, MD, discussed the relative benefits of therapeutic drug...
Research demonstrates that trough drug concentrations correlate to more positive outcomes in patients with immune-mediated diseases. At IAS 2020, David Hudesman, MD, and Adam Cheifetz, MD, discussed the relative benefits of therapeutic drug...
Research demonstrates that...
07/12/2020
Autoimmune

Stay In the Know

Autoimmune Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use